Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
about
Correlation between STK33 and the pathology and prognosis of lung cancer.Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.
P2860
Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Bi-specific molecule against E ...... n and death pathways in tumors
@ast
Bi-specific molecule against E ...... n and death pathways in tumors
@en
type
label
Bi-specific molecule against E ...... n and death pathways in tumors
@ast
Bi-specific molecule against E ...... n and death pathways in tumors
@en
prefLabel
Bi-specific molecule against E ...... n and death pathways in tumors
@ast
Bi-specific molecule against E ...... n and death pathways in tumors
@en
P2093
P2860
P1433
P1476
Bi-specific molecule against E ...... n and death pathways in tumors
@en
P2093
Deepak Bhere
Khalid Shah
Michal O Nowicki
Nicole Bassoff
Sean E Lawler
P2860
P2888
P356
10.1038/S41598-017-02483-9
P407
P577
2017-06-01T00:00:00Z
P6179
1085640578